α-Synuclein Seed Amplification Assay Classifies Parkinson Disease

MONDAY, April 17, 2023 -- α-synuclein seed amplification assays (SAAs) can classify people with Parkinson disease with high sensitivity and specificity, according to a study published in the May issue of The Lancet Neurology.
Andrew Siderowf, M.D.,...